Top Markets
#1 MON MON +2,760.08%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +52.36%
#4 eCash eCash +37.30%
#5 PinGo PinGo +24.63%
#6 Siren Siren +24.28%
#7 Collector Crypt Collector Crypt +23.96%
#8 SAFEcoin SAFEcoin +19.72%
#9 Janction Janction +19.66%
#10 Velvet Velvet +15.56%
Coin of the day
MON MON
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rangering i aksjer #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Aksjekurs
$0.30840035
Markedsverdi
$94.37M
Endring (1 dag)
0.00%
Endring (1 år)
-34.60%
Land
FR
Handel Sensorion SA (ALSEN)

Kategori

Healthcare
Historikk for aksjesplitt for Sensorion SA (ALSEN)
Aksjen Sensorion SA (symbol: ALSEN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Jul 13, 2026.
Én ALSEN-aksje kjøpt før Jul 13, 2026 tilsvarer i dag 0 ALSEN-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5 x199
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL